EquityZen Growth Technology Fund II LLC - Series 26
Raised
$3M
Investors
21
Min Invest
$50,134
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund II LLC - Series 26 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett on March 26, 2026. The fund raised $3.1M from 21 investors under Regulation D Rule 506(b) and 3(c) exemptions, with a $50K minimum investment. This entity is part of the EquityZen platform, which operates approximately 150 related fund vehicles focused on private equity investments.
This private equity fund vehicle follows a typical SPV structure with 506(b) private placement exemption and moderate minimum investment threshold. The $50K minimum places it in the accredited-investor tier, consistent with other EquityZen series funds that provide access to pre-IPO technology company shares through pooled structures.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
